1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Vitrolife AB (publ)

Vitrolife AB (publ)

VTRLY
Vitrolife AB (publ)US flagOther OTC
11.00
USD
- -
- -
1.49BMarket Cap

Total Valuation

Vitrolife AB (publ) carries a market capitalization of 1.49B, placing it among publicly traded companies globally. Its enterprise value stands at 20.25B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.49B
Enterprise Value20.25B

Share Statistics

Vitrolife AB (publ) currently has 135.45M shares outstanding.

Shares Outstanding135.45M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Vitrolife AB (publ) trades at a trailing price-to-earnings ratio of 42.16. The price-to-sales ratio is 5.42, and the price-to-book ratio stands at -12.61.

PE Ratio42.16
PS Ratio5.42
PB Ratio-12.61
P/TBV Ratio-26.31
P/FCF Ratio27.66
P/OCF Ratio27.64

Enterprise Valuation

On an enterprise value basis, Vitrolife AB (publ) trades at an EV/EBITDA multiple of 29.57 and an EV/FCF ratio of 29.18. The EV/Sales ratio of 5.72 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.57 provides insight into valuation relative to core operating earnings.

EV / Sales5.72
EV / EBITDA29.57
EV / EBIT29.57
EV / FCF29.18

Financial Position

Vitrolife AB (publ) maintains a current ratio of 3.41, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.

Current Ratio3.41
Quick Ratio1.44
Debt / Equity15.01
Debt / EBITDA2.91
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)2.70
Return on Invested Capital (ROIC)4.48
Return on Capital Employed (ROCE)125.27
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.63

Stock Price Statistics

Vitrolife AB (publ)'s stock has declined approximately -32.88591% over the past 52 weeks. The 50-day moving average sits at 11.00, while the 200-day moving average is 13.76.

Beta (5Y)N/A
52-Week Price Change-32.88591%
50-Day Moving Average11.00
200-Day Moving Average13.76
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Vitrolife AB (publ) generated 3.54B in revenue and converted that into 455.00M in net income, yielding earnings per share of 3.36. EBITDA reached 685.00M, while operating income came in at 685.00M.

Revenue3.54B
Gross Profit2.08B
Operating Income685.00M
Pretax Income610.00M
Net Income455.00M
EBITDA685.00M
EBIT685.00M
Earnings Per Share (EPS)3.36

Balance Sheet

Vitrolife AB (publ) holds 921.00M in cash and equivalents against 1.99B in total debt, resulting in a net debt position of 948.00M. Total book value stands at -1.52B, with working capital of 1.54B providing operational flexibility.

Cash & Cash Equivalents921.00M
Total Debt1.99B
Net Debt948.00M
Equity (Book Value)-1.52B
Book Value Per Share-11.23
Working Capital1.54B

Cash Flow

Vitrolife AB (publ) produced 694.00M in operating cash flow over the past twelve months.

Operating Cash Flow694.00M
Capital ExpendituresN/A
Free Cash Flow694.00M
FCF Per Share5.12

Margins

Vitrolife AB (publ) operates with a gross margin of 58.83, reflecting its pricing power and cost economics. The operating margin of 19.36 and net profit margin of 12.86 provide insight into operational efficiency.

Gross Margin58.83
Operating Margin19.36
Pretax Margin17.24
Profit Margin12.86
EBITDA Margin19.36

Dividends & Yields

The company's payout ratio of 32.82 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share1.10
Dividend YieldN/A
Payout Ratio32.82
Shareholder Yield1.47
FCF Yield3.62

Stock Splits

Vitrolife AB (publ)'s most recent stock split took place on November 2, 2018 with a 4:5 split ratio.

Last Split Date11/2/2018
Split Ratio4:5

Scores

Vitrolife AB (publ) posts an Altman Z-Score of 5.15, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score5.15